Trial
NCT00003407
Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Rush University Medical Center
Collaborators
National Cancer Institute (NCI)
Condition
Drug/Agent Toxicity by Tissue/Organ
Intervention
amifostine trihydrate
Why stopped
The P.I deceased.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-02-02